These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17410017)

  • 1. A critical look at the role of chemotherapy in older patients with non-small cell lung cancer.
    Jatoi A; Aranguren D
    J Thorac Oncol; 2007 Jan; 2(1):83-90. PubMed ID: 17410017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.
    Meoni G; Cecere FL; Lucherini E; Di Costanzo F
    J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of elderly patients with stage IV non-small-cell lung cancer.
    Weiss J; Stinchcombe TE
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):111-20. PubMed ID: 22149437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced non-small-cell lung cancer in the elderly.
    Vamvakas L; Saloustros E; Karampeazis A; Georgoulias V
    Clin Lung Cancer; 2009 May; 10(3):158-67. PubMed ID: 19443335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of non-small-cell lung cancer in older persons.
    Basche M; Kelly K
    Oncology (Williston Park); 2003 Jan; 17(1):31-9; discussion 43-4, 47-8. PubMed ID: 12599930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced non-small-cell lung cancer in the elderly.
    Gridelli C; Maione P; Rossi A; Ferrara ML; Castaldo V; Palazzolo G; Mazzeo N
    Lung Cancer; 2009 Dec; 66(3):282-6. PubMed ID: 19879012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy benefits older and younger non-small cell lung cancer patients alike.
    Barton MK
    CA Cancer J Clin; 2012; 62(5):279-80. PubMed ID: 22847502
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of advanced lung cancer in the elderly.
    Gajra A; Lichtman SM
    Hosp Pract (1995); 2011 Apr; 39(2):107-15. PubMed ID: 21576903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small cell lung cancer therapy in the elderly.
    Gridelli C; Rossi A; Maione P; Schettino C; Bareschino MA; Palazzolo G; Zeppa R; Ambrosio R; Barbato V; Sacco PC
    Clin Adv Hematol Oncol; 2011 May; 9(5):375-83. PubMed ID: 21685866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
    Aggarwal C; Langer CJ
    Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are we treating enough elderly patients with early stage non-small cell lung cancer?
    Pallis AG; Scarci M
    Lung Cancer; 2011 Nov; 74(2):149-54. PubMed ID: 21696842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatments for advanced stage non-small cell lung cancer.
    Stinchcombe TE; Socinski MA
    Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy for resectable non-small-cell lung cancer.
    Patel JD; Blum MG; Argiris A
    Oncology (Williston Park); 2004 Nov; 18(13):1591-602; discussion 1602-3, 1606, 1611-2. PubMed ID: 15648293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiochemotherapy in the elderly with lung cancer.
    Casas F; Kepka L; Agarwal JP; Dawotola D; Gaye P; Abdel-Wahab S; Vashkevitch L; Saghatelyan T; Perin B; Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1405-11. PubMed ID: 19827999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC).
    Firat S; Pleister A; Byhardt RW; Gore E
    Am J Clin Oncol; 2006 Jun; 29(3):252-7. PubMed ID: 16755178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.
    Rigas JR; Dragnev KH
    Oncologist; 2005 Jan; 10(1):22-33. PubMed ID: 15632250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of advanced non-small-cell lung cancer in elderly populations.
    Lilenbaum R
    Clin Lung Cancer; 2003 Nov; 5(3):169-73. PubMed ID: 14667272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triplet chemotherapy combinations with new agents: is there a rationale?
    Bunn PA
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.